KCP
AGN

Kenmare Capital Partners’s Allergan plc AGN Stock Holding History

Kenmare Capital Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-55,100
Closed -$9.27M – 19
2018
Q1 		$9.27M Buy
55,100
+2,100
+4% +$352K 9.93% 5
2017
Q4 		$8.67M Buy
53,000
+49,650
+1,482% +$8.91M 9.46% 4
2017
Q3 		$687K Sell
3,350
-11,915
-78% -$2.77M 0.85% 16
2017
Q2 		$3.71M Buy
15,265
+400
+3% +$94K 4.44% 8
2017
Q1 		$3.55M Buy
14,865
+200
+1% +$46.6K 3.45% 12
2016
Q4 		$3.08M Buy
+14,665
New +$3.04M 2.34% 14

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Kenmare Capital Partners's AGN Position: Q2 2018 in Review

Kenmare Capital Partners sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 55,100 shares — an estimated $9.27M sold.

Kenmare Capital Partners first reported a position in AGN in Q4 2016 and held it in 6 quarters. The position peaked at $9.27M in Q1 2018. 1,044 funds tracked by Wall St. Rank hold AGN as of Q2 2018.

  • Kenmare Capital Partners reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
  • Kenmare Capital Partners sold 55,100 Allergan plc shares in Q2 2018, an estimated $9.27M.
  • Kenmare Capital Partners first reported a position in Allergan plc in Q4 2016 and held it in 6 quarters.
  • Kenmare Capital Partners's Allergan plc position peaked at $9.27M in Q1 2018.
  • 1,044 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.

Based on Kenmare Capital Partners's 13F filing for Q2 2018, filed 14 Aug 2018.